Luisa Soares Miranda: Excited to Share our Latest Publication on Trastuzumab Deruxtecan in Previously Treated HER2-Low MBC
Luisa Soares Miranda, Medical Oncology Resident at Santo António University Hospital Center, shared a post on LinkedIn:
“Excited to share our latest publication:
‘Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population’
This work was only possible thanks to the outstanding teamwork. Truly grateful to everyone involved!”
Title: Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population
Authors: Luísa Soares Miranda, Maria João Sousa, Miguel Martins Braga, Marisa Couto, Isabel Vieira Fernandes, Francisca Abreu, Inês Eiriz, Catarina Lopes Fernandes, Alice Fonseca Marques, Maria Teresa Marques, Raquel Romão, Fernando Gonçalves, Joana Simões, António Araújo
Read the Full Article on Cancers Journal
More posts featuring Trastuzumab Deruxtecan.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023